CMS can terminate private Medicare plans with poor Star Ratings again
(By Morgan Haefner for Becker’s Hospital Review) CMS informed Medicare Advantage and Part D drug plans that it will begin
Read More
Part D/Prescription Drugs
With one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling
(By Meghana Keshavan for STAT) Bob Field was set to kick off his second course of BCG — a potent immunotherapy that
Read More‘Everyone is at fault’: With insulin prices skyrocketing, there’s plenty of blame to go around
(By Nicholas Florko for STAT) WASHINGTON — Fifteen years ago, a patient with diabetes might have paid $175.57 for a
Read MoreThe High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
(By Michelle Andrews for Kaiser Health News) For some older people, the joy of sex may be tempered by financial
Read MoreDischarged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
(By Rachel Bluth for Kaiser Health News) The last time heroin landed Marissa Angerer in a Midland, Texas, emergency room
Read MoreCan California Beat The Federal Government In Lowering Drug Prices?
(By Samantha Young for Kaiser Health News) California Gov. Gavin Newsom says he’s done waiting for the federal government to
Read MoreBugs Vs. Superbugs: Insects Offer Promise In Fight Against Antibiotic Resistance
(By Paul Chisholm for NPR) Nobody likes a cockroach in their house. But before you smash the unwelcome intruder, consider
Read MoreDrug-Price Debate Targets Pharmacy Benefit Managers
(By Michael Ollove for Stateline an initiative of The Pew Charitable Trusts) In the bipartisan drive to control prescription drug
Read MorePrepare for grilling: 7 questions for 7 pharma execs who’ll testify before Congress about prices
(By Ed Silverman for STAT) After some very public cajoling, executives from some of the world’s largest drug makers have
Read MoreOptumRx sets demands for drugmaker price reductions
(By Alia Paavola for Becker’s Hospital Review) OptumRx, UnitedHealth Group’s pharmacy benefit manager unit, reportedly sent a letter to pharmaceutical
Read More